Gauri Mankekar

Dr. Gauri Mankekar

Otolaryngology Head Neck Surgery, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
IEI D Erbele
I D Erbele
MFM R Fink
M R Fink
GMGauri Mankekar
Gauri Mankekar
LSL S Son
L S Son
RMR Mehta
R Mehta
MAMoises A Arriaga
Moises A Arriaga
Objective: This study aimed to describe the microscopic over-under cartilage tympanoplasty technique, provide hearing results and detail clinically significant complications.Method: This was a retrospective case series chart review study of over-under cartilage tympanoplasty procedures performed by the senior author between January 2015 and January 2019 at three tertiary care centres. Cases were excluded for previous or intra-operative cholesteatoma, if a mastoidectomy was performed during the procedure or if ossiculoplasty was performed. Hearing results and complications were obtained.Results: Sixty-eight tympanoplasty procedures met the inclusion criteria. The median age was 13 years (range, 3–71 years). The mean improvement in pure tone average was 6 dB (95 per cent confidence interval 4–9 dB;p <0.0001). The overall perforation closure rate was 97 per cent (n =66). Revision surgery was recommended for a total of 6 cases (9 per cent) including 2 post-operative perforations, 1 case of middle-ear cholesteatoma and 3 cases of external auditory canal scarring.Conclusion: Over-under cartilage tympanoplasty is effective at improving clinically meaningful hearing with a low rate of post-operative complications.

14 April 2020 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
PDF file
KCKelsey Casano
Kelsey Casano
GGGerard Giangrosso
Gerard Giangrosso
GMGauri Mankekar
Gauri Mankekar
ASAlexander Sevy
Alexander Sevy
RMRahul Mehta
Rahul Mehta
MAMoises Arriaga
Moises Arriaga

6 August 2023 in Otolaryngologic Clinics of North America
Verified
Journal Article
Closed access
GMGauri Mankekar
Gauri Mankekar
PEPayam Entezami
Payam Entezami

8 May 2025 in Children
Verified
Journal Article
Open access
PDF file
ACAmber Cradeur
Amber Cradeur
AJAaron Jackson
Aaron Jackson
EWErin Ware
Erin Ware
TFTorrey Louise Fourrier
Torrey Louise Fourrier
GMGauri Mankekar
Gauri Mankekar
Background/Objectives: Congenital cytomegalovirus (cCMV) infection is a significant cause of pediatric hearing loss. However, the prevalence and characteristics of cCMV-related hearing loss remain unclear. Methods: A comprehensive search of major databases (PubMed, Scopus, and Web of Science) was conducted to identify studies and reviews published between 2000 and 2024 that investigated cCMV infection, testing for cCMV, and pediatric hearing loss. Studies were included if they reported on the prevalence, characteristics, current policies, and recommendations for universal cCMV testing in newborns. Results: This review highlights key issues: cCMV is a significant and treatable cause of pediatric hearing loss; most cCMV-related hearing loss cases presented with bilateral and profound hearing impairment; and cCMV testing is performed only for babies who fail newborn hearing screening. Conclusions: This narrative review highlights the significant association between cCMV infection and pediatric hearing loss. Currently, targeted cCMV testing is recommended for newborns who fail newborn hearing screening. Universal cCMV testing may facilitate early diagnosis and directed intervention and could be cost-effective in the long run.

1 March 2023 in Cureus
Verified
Journal Article
Open access
PDF file
MRMichael Rockwell
Michael Rockwell
PSPatrick Spiller
Patrick Spiller
ACAreli K. Cuevas-Ocampo
Areli K. Cuevas-Ocampo
AMAlexandre Malek
Alexandre Malek
GMGauri Mankekar
Gauri Mankekar
This report describes the diagnosis and treatment of a patient with a rare fungal infection of the external ear, as well as a review of the literature. A 76-year-old Caucasian gentleman from rural southern United States with diabetes and hypertension was referred to our clinic for intractable left otalgia, otorrhea, headaches, and an exophytic lesion in the left external ear since five months. There was no pertinent travel history. Biopsy by an outside otolaryngologist was inconclusive. Repeat biopsy under anesthesia revealed morphological characteristics consistent with histoplasmosis. Intravenous amphotericin B and later oral antifungal agent voriconazole led to improvement in symptoms. The clinical presentation resembled a malignancy. A high index of clinical suspicion, histologic confirmation with deep tissue biopsy, and culture are essential for diagnostic confirmation followed by treatment with systemic antifungals. A multidisciplinary team approach is necessary to manage this rare condition.

1 February 2020 in Otology & Neurotology
Verified
Journal Article
Closed access
IEIsaac D. Erbele
Isaac D. Erbele
LMLaura S. Miller
Laura S. Miller
GMGauri Mankekar
Gauri Mankekar
CMChristian E. Morel
Christian E. Morel
DADwayne T. Anderson
Dwayne T. Anderson
MAMoises A. Arriaga
Moises A. Arriaga
Objective: Cochlear obliteration after vestibular schwannoma excision has been noted, with implications on cochlear implantation. Early postoperative cochlear enhancement with gadolinium on magnetic resonance imaging (MRI) has also been observed. Timing of enhancement and association with obliteration is described here. Study Design: Retrospective case review. Setting: Tertiary referral center, ambulatory. Patients: Patients receiving vestibular schwannoma excision surgery by the senior author performed at one institution between January 2015 and July 2017 with postoperative MRIs Intervention: Diagnostic. Main Outcome Measure(s): The imaging characteristics on postoperative MRIs examined were loss of fluid signal on postoperative T2 images and cochlear enhancement on gadolinium enhanced T1 images. In the patients receiving labyrinthine sparing procedures, presence of postoperative hearing was evaluated. Results: Of the 42 patients evaluated, 24 received the translabyrinthine approach and 18 received a labyrinth sparing surgery. Twenty-nine had evidence of cochlear enhancement on T1 with gadolinium contrast, and 27 had evidence of cochlear obliteration on T2 images. The odds ratio of patients with cochlear enhancement having obliteration was 30.0:1 (p < 0.0001). Intense cochlear enhancement (n = 21) appeared a median of 163 days after surgery, and complete or near complete obliteration (n = 18) appeared a median of 480 days after surgery, a statistically significant difference (p < 0.001). Within the labyrinth sparing group, there was no statistically significant association between hearing loss and cochlear obliteration or enhancement. Conclusions: Cochlear enhancement is correlated with cochlear obliteration and may precede it.